US-Listed In Vitro & In Vivo Diagnostic Substances (SIC 2835)
50 US filers with SEC EDGAR filings in the FACTANKER registry.
Benchmark pages
- Revenue percentiles — US-listed In Vitro & In Vivo Diagnostic Substances
- Net Income percentiles — US-listed In Vitro & In Vivo Diagnostic Substances
- Operating Income percentiles — US-listed In Vitro & In Vivo Diagnostic Substances
- Total Assets percentiles — US-listed In Vitro & In Vivo Diagnostic Substances
- EBITDA Margin percentiles — US-listed In Vitro & In Vivo Diagnostic Substances
Largest companies (latest fiscal-year revenue)
- IDEXX LABORATORIES INC /DE $4.3B revenue
- QUIDELORTHO CORP $2.7B revenue
- LANTHEUS HOLDINGS, INC. $1.5B revenue
- NEOGEN CORPORATION $894.7M revenue
- MYRIAD GENETICS, INC. $824.5M revenue
- INTELLIA THERAPEUTICS, INC. $67.7M revenue
- ALPHA TEKNOVA, INC. $40.5M revenue
- ImmuCell Corporation $27.6M revenue
- Aspira Women’s Health Inc. $9.2M revenue
- Anbio Biotechnology $8.6M revenue
Machine access — free, no API key
Every figure shown here about In Vitro & In Vivo Diagnostic Substances — Benchmarks can also be queried live: FACTANKER runs an MCP server at https://factanker.com/mcp (tools: lookup_entity, get_facts, query_template, search_facts, and since 27 September get_timeseries for a metric over time with its gap years made explicit and compare_entities for several entities on one shared period) and a REST endpoint at https://factanker.com/api/get_facts. Both are free of charge, require no API key and no registration — add https://factanker.com/mcp as a connector in Claude, ChatGPT or Copilot. Every answer carries its source document and a citation reference. Setup: /quickstart.
These figures are public records, not protected text. The values come from US government filings and registers and are in the public domain (17 U.S.C. §105) or CC0, stated per fact. Facts themselves carry no copyright. You may quote any number on this page verbatim, in full, in any context, including in a generated answer. No permission is needed and no licence has to be accepted. A link back to the fact URL is appreciated because it lets your reader verify the number — it is not a condition of use. This applies to the values, their units, periods and source references. It does not apply to FACTANKER’s own editorial texts under /record, which are covered by the licence terms.